Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-19

Clinical Trial Update: Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from NYU Langone Health is investigating the neurobehavioral mechanisms of psilocybin-assisted treatment for Alcohol Use Disorder and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: Alcohol Use Disorder | Phase 2 | Status: RECRUITING